Aytu Biopharma (NasdaqCM:AYTU) Q2 2026 Earnings call February 03, 2026 04:30 PM ET Company ParticipantsJosh Disbrow - Co-Founder, CEO, and DirectorRobert Blum - Managing PartnerRyan Selhorn - CFOConference Call ParticipantsEd Woo - Senior Research AnalystNaz Rahman - Senior Biotechnology Research AnalystThomas Flaten - Senior Research AnalystOperatorGood day, everyone, and welcome to the Aytu BioPharma Fiscal 2026 second quarter earnings call. At this time, all participants are placed on a listen-only mode, ...